Your browser doesn't support javascript.
loading
Metastatic recurrence in colorectal cancer arises from residual EMP1+ cells.
Cañellas-Socias, Adrià; Cortina, Carme; Hernando-Momblona, Xavier; Palomo-Ponce, Sergio; Mulholland, Eoghan J; Turon, Gemma; Mateo, Lidia; Conti, Sefora; Roman, Olga; Sevillano, Marta; Slebe, Felipe; Stork, Diana; Caballé-Mestres, Adrià; Berenguer-Llergo, Antonio; Álvarez-Varela, Adrián; Fenderico, Nicola; Novellasdemunt, Laura; Jiménez-Gracia, Laura; Sipka, Tamara; Bardia, Lidia; Lorden, Patricia; Colombelli, Julien; Heyn, Holger; Trepat, Xavier; Tejpar, Sabine; Sancho, Elena; Tauriello, Daniele V F; Leedham, Simon; Attolini, Camille Stephan-Otto; Batlle, Eduard.
Afiliação
  • Cañellas-Socias A; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
  • Cortina C; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain.
  • Hernando-Momblona X; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
  • Palomo-Ponce S; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain.
  • Mulholland EJ; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
  • Turon G; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain.
  • Mateo L; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
  • Conti S; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain.
  • Roman O; Gastrointestinal Stem Cell Biology Lab, Wellcome Centre Human Genetics, University of Oxford, Oxford, UK.
  • Sevillano M; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
  • Slebe F; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
  • Stork D; Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
  • Caballé-Mestres A; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
  • Berenguer-Llergo A; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
  • Álvarez-Varela A; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain.
  • Fenderico N; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
  • Novellasdemunt L; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
  • Jiménez-Gracia L; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
  • Sipka T; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
  • Bardia L; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
  • Lorden P; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain.
  • Colombelli J; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
  • Heyn H; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
  • Trepat X; CNAG-CRG, Centre for Genomic Regulation, The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
  • Tejpar S; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
  • Sancho E; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
  • Tauriello DVF; CNAG-CRG, Centre for Genomic Regulation, The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
  • Leedham S; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
  • Attolini CS; CNAG-CRG, Centre for Genomic Regulation, The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
  • Batlle E; Universitat Pompeu Fabra (UPF), Barcelona, Spain.
Nature ; 611(7936): 603-613, 2022 Nov.
Article em En | MEDLINE | ID: mdl-36352230
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Receptores de Superfície Celular / Neoplasia Residual / Metástase Neoplásica / Proteínas de Neoplasias / Recidiva Local de Neoplasia Tipo de estudo: Prognostic_studies Idioma: En Revista: Nature Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Receptores de Superfície Celular / Neoplasia Residual / Metástase Neoplásica / Proteínas de Neoplasias / Recidiva Local de Neoplasia Tipo de estudo: Prognostic_studies Idioma: En Revista: Nature Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Espanha